[Therapy of psychoautonomic disorders. Clinical double-blind duplex study with dipotassium chlorazepate and bromazepam].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001960:Bromazepam / Q000627:therapeutic use*; D003009:Clorazepate Dipotassium / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium; D001960:Bromazepam
Therapie psychovegetativer und psychosomatischer Störungen. Klinische doppelblinde Verbundstudie mit Dikaliumclorazepat und Bromazepam.